Vardenafil efficacy for the treatment of persistent pulmonary hypertension of the newborn

doi:10.5409/wjcp.118862

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

(3)

(1)

(0)

(21)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Clin Pediatr. Sep 9, 2026; 15(3): 118862
Published online Sep 9, 2026. doi: 10.5409/wjcp.118862

Open in New Tab Full Size Figure Download Figure

Figure 1 Participant’s flow diagram. sPAP: Pulmonary artery systolic pressure; q24h: Every 24 hourly.

Open in New Tab Full Size Figure Download Figure

Figure 2 Pulmonary artery flow velocity differences between groups.

Citation: El-Hindi S. Vardenafil efficacy for the treatment of persistent pulmonary hypertension of the newborn. World J Clin Pediatr 2026; 15(3): 118862
URL: https://www.wjgnet.com/2219-2808/full/v15/i3/118862.htm
DOI: https://dx.doi.org/10.5409/wjcp.118862

El-Hindi S. Vardenafil efficacy for the treatment of persistent pulmonary hypertension of the newborn. World J Clin Pediatr 2026; 15(3): 118862 [DOI: 10.5409/wjcp.118862]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.